There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Abcam (ABCM) with bullish sentiments.
Abcam (ABCM)
Leerink Partners analyst Puneet Souda initiated coverage with a Buy rating on Abcam on November 16 and set a price target of $22.00. The company’s shares closed last Wednesday at $23.08.
According to TipRanks.com, Souda is a 5-star analyst with an average return of 36.3% and a 79.0% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience.
Currently, the analyst consensus on Abcam is a Moderate Buy with an average price target of $22.33.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
